Kestra Advisory Services
BMRN icon

Kestra Advisory Services’s BioMarin Pharmaceuticals BMRN Stock Holding History

Kestra Advisory Services’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$271K Buy
4,520
+857
+23% +$54K ﹤0.01% 3046
2026
Q2 		$210K Buy
+3,663
New +$201K ﹤0.01% 3077
2024
Q4 		– Sell
-9,754
Closed -$686K – 2672
2024
Q3 		$686K Buy
9,754
+620
+7% +$51.8K ﹤0.01% 1558
2024
Q2 		$752K Sell
9,134
-9,251
-50% -$770K ﹤0.01% 1500
2024
Q1 		$1.61M Buy
18,385
+3,095
+20% +$277K 0.01% 984
2023
Q4 		$1.47M Buy
15,290
+1,456
+11% +$129K 0.01% 949
2023
Q3 		$1.22M Buy
13,834
+2,817
+26% +$251K 0.01% 902
2023
Q2 		$955K Buy
11,017
+712
+7% +$67K 0.01% 1002
2023
Q1 		$1M Buy
10,305
+558
+6% +$57.8K 0.01% 947
2022
Q4 		$1.01M Buy
9,747
+3,001
+44% +$282K 0.01% 1053
2022
Q3 		$572K Buy
6,746
+449
+7% +$40K 0.01% 1243
2022
Q2 		$522K Sell
6,297
-1,714
-21% -$136K 0.01% 1308
2022
Q1 		$618K Buy
8,011
+4,277
+115% +$358K 0.01% 1172
2021
Q4 		$330K Sell
3,734
-237
-6% -$19.6K ﹤0.01% 1547
2021
Q3 		$307K Buy
3,971
+300
+8% +$23.7K ﹤0.01% 1652
2021
Q2 		$306K Buy
3,671
+408
+13% +$32.3K ﹤0.01% 1552
2021
Q1 		$246K Buy
+3,263
New +$267K ﹤0.01% 1590

Other funds holding BMRN

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
ARGA Investment Management
ARGA Investment Management Stamford, Connecticut $3.94B AUM 28.9% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Kestra Advisory Services's BMRN Position: Q3 2026 in Review

Kestra Advisory Services increased its BioMarin Pharmaceuticals (BMRN) stake by 23% in Q3 2026, buying an estimated $54K and bringing the position to 4,520 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #3046.

Kestra Advisory Services first reported a position in BMRN in Q1 2021 and has held it in 17 quarters since. The position peaked at $1.61M in Q1 2024. 271 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.

  • Kestra Advisory Services held 4,520 shares of BioMarin Pharmaceuticals worth $271K as of Q3 2026.
  • Kestra Advisory Services bought 857 BioMarin Pharmaceuticals shares in Q3 2026, an estimated $54K.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Kestra Advisory Services's portfolio in Q3 2026, its #3046 holding.
  • Kestra Advisory Services first reported a position in BioMarin Pharmaceuticals in Q1 2021 and has held it in 17 quarters since.
  • Kestra Advisory Services's BioMarin Pharmaceuticals position peaked at $1.61M in Q1 2024.
  • 271 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.

Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.